Seattle Genetics Inc (NASDAQ:SGEN)

35.12
Delayed Data
As of Mar 04
 -0.03 / -0.09%
Today’s Change
30.05
Today|||52-Week Range
55.46
+9.31%
Year-to-Date

Today’s Trading

Previous close35.15
Today’s open34.92
Day’s range34.59 - 35.54
Volume935,832
Average volume (3 months)1,376,399
Market cap$4.4B
Dividend yield--
Data as of 03/04/2015

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-16.13%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+6.50%
P/E ratioNM
Price/Sales13.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.05-0.16%
RCPTReceptos Inc+3.01+2.41%
ACADACADIA Pharmaceutica...0.000.00%
NBIXNeurocrine Bioscienc...+0.41+1.00%
Data as of 03/04/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$286.8M
Annual profit (last year)-$76.1M
Net profit margin-26.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account